{"database": "openregs", "table": "documents", "rows": [["FDA-1975-N-0336-0121", "FDA", "FDA-1975-N-0336", "Drugs for Human Use; Drug Efficacy Study Implementation; Oral Prescription Drugs Containing an Anticholinergic or Antispasmodic in Combination With a Sedative, and\nSingle-Entity Antispasmodic Drug Products, in Oral Dosage Form; Withdrawal of Hearing Requests; Final Resolution of Drug Efficacy Study Implementation", "Notice", "Announcement", "2022-04-25T04:00:00Z", 2022, 4, "2022-04-25T04:00:00Z", null, "2022-04-25T12:23:39Z", "2022-08740", 0, 0, "0900006485031b82"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-1975-N-0336-0121"], "units": {}, "query_ms": 29.30861501954496, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}